Charles River Laboratories International Inc (CRL)
239.55
-0.58
(-0.24%)
USD |
NYSE |
Apr 24, 13:53
Charles River Laboratories International Revenue (Quarterly): 1.013B for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.013B |
| September 30, 2023 | 1.027B |
| June 30, 2023 | 1.060B |
| March 31, 2023 | 1.029B |
| December 31, 2022 | 1.100B |
| September 30, 2022 | 989.16M |
| June 30, 2022 | 973.13M |
| March 31, 2022 | 913.93M |
| December 31, 2021 | 905.05M |
| September 30, 2021 | 895.94M |
| June 30, 2021 | 914.61M |
| March 31, 2021 | 824.57M |
| December 31, 2020 | 790.99M |
| September 30, 2020 | 743.30M |
| June 30, 2020 | 682.58M |
| March 31, 2020 | 707.06M |
| December 31, 2019 | 691.14M |
| September 30, 2019 | 667.95M |
| June 30, 2019 | 657.57M |
| March 31, 2019 | 604.57M |
| December 31, 2018 | 601.53M |
| September 30, 2018 | 585.30M |
| June 30, 2018 | 585.30M |
| March 31, 2018 | 493.97M |
| December 31, 2017 | 478.48M |
| Date | Value |
|---|---|
| September 30, 2017 | 464.23M |
| June 30, 2017 | 469.13M |
| March 31, 2017 | 445.76M |
| December 31, 2016 | 466.79M |
| September 30, 2016 | 425.72M |
| June 30, 2016 | 434.06M |
| March 31, 2016 | 354.87M |
| December 31, 2015 | 353.85M |
| September 30, 2015 | 349.46M |
| June 30, 2015 | 339.57M |
| March 31, 2015 | 320.41M |
| December 31, 2014 | 329.55M |
| September 30, 2014 | 327.57M |
| June 30, 2014 | 341.18M |
| March 31, 2014 | 299.37M |
| December 31, 2013 | 289.23M |
| September 30, 2013 | 292.13M |
| June 30, 2013 | 292.93M |
| March 31, 2013 | 291.24M |
| December 31, 2012 | 280.14M |
| September 30, 2012 | 278.69M |
| June 30, 2012 | 284.72M |
| March 31, 2012 | 285.98M |
| December 31, 2011 | 290.96M |
| September 30, 2011 | 277.58M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
657.57M
Minimum
Jun 2019
1.100B
Maximum
Dec 2022
872.96M
Average
905.05M
Median
Dec 2021
Revenue (Quarterly) Benchmarks
| Cardinal Health Inc | 57.44B |
| Stryker Corp | 5.815B |
| DaVita Inc | 3.146B |
| Inotiv Inc | 135.50M |
| Medpace Holdings Inc | 498.40M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 187.08M |
| Total Expenses (Quarterly) | 880.55M |
| EPS Diluted (Quarterly) | 3.64 |
| Enterprise Value | 14.76B |
| Gross Profit Margin (Quarterly) | 35.92% |
| Profit Margin (Quarterly) | 18.46% |
| Earnings Yield | 3.85% |
| Operating Earnings Yield | 5.01% |
| Normalized Earnings Yield | 3.853 |